Boies, Schiller & Flexner LLP enjoys one of the most selective and sophisticated class action practices in the country. We have been trial counsel in two successful class action jury trials against non-settling defendants in In re Vitamins Antitrust Litigation (D.D.C.) (a $49.5 million verdict in 2004 before trebling) and In re Scrap Metal Antitrust Litigation (an $11.5 million verdict in 2006 before trebling). The Firm acted as lead counsel in In re Auction Houses Antitrust Litigation (S.D.N.Y.) (a $512 million settlement that another plaintiffs' counsel described as "the most outstanding result I have ever heard of in the history of the antitrust laws.").
Boies, Schiller & Flexner also served as co-lead counsel in In re Vitamins Antitrust Litigation (D.D.C.) (a $1.1 billion initial settlement followed by additional settlements of over $200 million); In re Cardizem CD Antitrust Litigation (E.D. Mich.) (a $110 million settlement); In re Alcatel Alsthom Securities Litigation (E.D. Texas) (a $75 million settlement); In re Buspirone Antitrust Litigation (S.D.N.Y.) (a $220 million settlement); In re Terazosin Hydrochloride Antitrust Litigation (S.D.Fla.) (a $72.5 million settlement); In re First Databank Antitrust Litigation (D.D.C.) (a $24 million settlement); In re Scrap Metal Antitrust Litigation (N.D. Ohio) (an $11 million in settlements on top of jury verdict). The Firm is lead counsel in van Roden and Bernten v. Henri Termeer, Genzyme Corp., et al. (S.D.N.Y.), a federal class action related to publicly traded "tracking stock" that settled in early August 2007, with defendants agreeing to pay $64 million to the class. We also have initiated the first class actions uncovering cartels for Chinese products exported to the United States, including in the Vitamin C industry in China (In re Vitamin C Antitrust Litigation (E.D.N.Y.) and among Magnesite exporters in China (D.N.J.). The Firm also has a major pro bono case on behalf of Florida's 1.2 million plus children on Medicaid now in trial.
Our history of representing plaintiff classes gives us a perspective that is unique among defense counsel. This broader experience has proven effective in our representation of defendants in class actions, including a number of Fortune 500 companies in class action cases involving alleged securities fraud, antitrust and consumer protection violations.